Find Academic Supervisors

• Medical Oncology
• Lung Cancer
• Clinical Trials
• +6 more

Giorgio Vittorio Scagliotti is an Honorary Professor in the Department of Oncology at the University of Turin. His primary focus is on medical oncology, particularly lung cancer and malignant mesothelioma. He leads research on molecular mechanisms, clinical trial design, and therapeutic strategies in oncology, including immune checkpoint inhibitors and pharmacogenomics. Role: Honorary Professor, Department of Oncology, University of Turin. Research: Lung cancer classification, treatment protocols, molecular biomarkers, and immunotherapy efficacy in mesothelioma. Key contributions include the 2021 WHO Lung Cancer Classification and systematic reviews on immune checkpoint inhibitors in mesothelioma. He oversees clinical trials evaluating drug combinations, including phase II studies on niraparib/dostarlimab and gemcitabine/cisplatin regimens. His work bridges translational research and clinical practice, addressing treatment resistance and biomarker-driven therapies. Publications span over 40 years, with recent emphasis on genomic profiling (EPROPA study), machine learning in treatment selection (TRIDENT trial), and imaging innovations for pulmonary nodule management (PINPOINT study). He collaborates with international consortia like the IASLC for global oncology advancements.

• Epigenetics
• DNA Methylation
• MicroRNA
• +9 more

Emma Raitoharju is an Academy Research Fellow in Biomedicine at Tampere University, Faculty of Medicine and Health Technology. Her research is deeply embedded in epigenetics, particularly DNA methylation and microRNA, with strong applications in cardiovascular disease, aging, and public health. She is a key contributor to the long-term Young Finns Study , leveraging decades of data to explore epigenetic aging and resilience. Her research interests center on epigenetic mechanisms in disease development, with a focus on biological aging , vascular health , and gene expression regulation . She investigates how lifestyle factors such as sleep disturbances and shift work influence epigenetic aging, and how early-life resilience impacts long-term health trajectories. Her work bridges molecular biology with population-level health outcomes. The recent trend in her publications reveals a strong focus on epigenetic biomarkers of aging and disease, particularly using longitudinal cohort data. Her studies integrate microRNA profiling , DNA methylation analysis , and clinical phenotypes to uncover mechanisms linking stress, aging, and cardiovascular risk. She frequently collaborates with leading Finnish researchers in genetics and epidemiology. Emma Raitoharju actively contributes to scientific discourse through conference presentations, including talks on transgenerational stress effects and clinical trials. She has co-authored a doctoral thesis and contributed to significant datasets, such as the methylation profile of VTRNA2-1 across tissues and populations. While no formal students are listed, her collaborative output suggests mentorship within research teams. She has not received any explicitly mentioned scientific awards in the provided text. Her work is primarily conducted within the Young Finns Study research network, a collaborative, multidisciplinary team focused on cardiovascular and metabolic health across the lifespan. This team includes experts in epidemiology, genetics, psychology, and clinical medicine, enabling integrative research on complex health outcomes.

• Prostate Cancer
• Oncology
• Urologic Oncology
• +14 more

Teemu Murtola is a Professor at the University of Tampere, affiliated with the Faculty of Medicine and Life Sciences and the Department of Surgery, within the KIRU (Surgical Responsibility Area). His research focuses on urologic oncology, particularly prostate cancer, including risk factors, treatment outcomes, and population-based screening impacts. His research interests span prostate cancer epidemiology , pharmacoepidemiology (statins, NSAIDs, antihypertensives), androgen deprivation therapy , cancer screening , and patient-centered outcomes such as sexuality, relationships, and physical activity during treatment. He also investigates renal and breast cancer in relation to medication use. The recent articles highlight a consistent focus on medication effects on cancer outcomes, patient experiences, and population-level data analysis. His work bridges clinical practice and public health, contributing significantly to cancer prevention and survivorship research. Scientific Contributions: Extensive publication record in high-impact oncology journals Contributor to UN Sustainable Development Goal 3 (Good Health and Well-being) Active in national and international research collaborations He supervises medical licentiate candidates and doctoral students, participates in thesis evaluations, and reviews funding applications. His activities include invited lectures, conference presentations, and public talks on prostate cancer care and rehabilitation. He has also held visiting positions abroad, including at Tartu University. He leads and contributes to research datasets on antihypertensive drugs and prostate cancer risk, emphasizing open science and data transparency. His team collaborates closely with experts in urology, epidemiology, and patient support.

Manzur Rahman FaraziView profile

Researcher

• Biostatistics
• Epidemiology
• Genomics
• +6 more

Manzur Rahman Farazi, PhD serves as a Statistical Research Scientist II in the Department of Biostatistics at the Medical College of Wisconsin (MCW). His work spans biostatistical research in oncology, pediatric trauma, and public health, with a focus on translational medical research. Farazi has contributed to studies examining the impact of the COVID-19 pandemic on pediatric healthcare, telemedicine efficacy, and genetic factors influencing treatment outcomes in hematopoietic stem cell transplantation. Education & Professional Background: PhD in Biostatistics (not explicitly stated in source text, inferred from title) Research Interests: Farazi’s research emphasizes leveraging biostatistical methods to address clinical and public health challenges. Key areas include: Polygenic risk scoring for radiation therapy toxicity Geospatial analysis of pediatric surgical care distribution Health disparities in trauma outcomes Genetic determinants of stem cell transplantation success Evaluation of telemedicine adoption in pediatric surgery Publications & Collaborations: His recent work includes high-impact studies on: Regional pediatric injury patterns during the pandemic Donor germline variants in MDS stem cell transplants Bladder toxicity polygenic risk scores in prostate cancer Labs & Teams: Collaborates within MCW’s Biostatistics department and multidisciplinary teams including the Midwest Pediatric Surgery Consortium, contributing to large-scale epidemiological analyses.

Sefer BadayView profile

Assistant Professor

• Bioinformatics
• Computational Biology
• Molecular Dynamics Simulation
• +3 more

Sefer Baday is an Assistant Professor at Istanbul Technical University's Informatics Institute, Department of Informatics Applications , holding a PhD from the University of Basel (2013). His interdisciplinary research bridges computational biology, structural bioinformatics, and drug discovery. Education: PhD (Computational Biology, University of Basel), MA (Computational Sciences, Koç University), Licence (Chemical Engineering, Bogazici University) Positions: Assistant Professor (2015–present, Istanbul Technical University); Research Assistant (2014–2015, University of Cambridge; 2009–2014, University of Basel) Research Interests: Focus on computational modeling of biological systems, including: Mechanistic studies of ion channels (Ryanodine receptors) Machine learning for molecular docking acceleration Force field optimization for drug interactions Peptide engineering for therapeutic applications Antiviral and anticancer drug development Plant nutrient transport mechanisms Publication Trends : Recent work (2021–2025) emphasizes molecular docking , CHARMM force field , machine learning , and drug repurposing , with applications in cardiovascular disease , cancer , and virology . Earlier studies (2007–2016) focused on protein folding , ammonium transport , and biomaterials . Projects : Leading six funded initiatives, including: GPX4 Ligand Recognition (2025–2027, BAP) Ryanodine Receptor Inhibitors (2020–2023, TUBITAK) Enzalutamide Resistance (2017–2020, TUBITAK) Alzheimer's Enzyme Inhibitors (2017–2020, BAP) Stapled Peptide Linkers (2016–2017, TUBITAK) Collaborations span institutions like University of Cambridge, University of Basel, and Koç University, with co-authors in Turkey, Switzerland, and Germany. Methodologies include molecular dynamics simulations , machine learning , and CHARMM force field development. Techniques : Expert in computational approaches to protein structure-function relationships, ligand binding, and nanomaterial design, with applications in drug discovery and regenerative medicine.

Nicholas J. RockwoodView profile

Assistant Professor

• Psychometrics
• Quantitative Psychology
• Statistics
• +4 more

Nicholas J. Rockwood is an Assistant Research Professor at the School of Behavioral Health, Loma Linda University, and a Senior Psychometrician at RTI Health Solutions. He holds a PhD in quantitative psychology from The Ohio State University, an MA in quantitative psychology, and an MA in applied statistics. His research focuses on psychometric methods, particularly generalized latent variable modeling, multilevel mediation, and software development for statistical analysis. Education: PhD in Quantitative Psychology, The Ohio State University (2019) MA in Quantitative Psychology, The Ohio State University MA in Applied Statistics, The Ohio State University BA, California State University, San Bernardino (2014) Research interests emphasize psychometrics, statistical methodology, and software tools like PLmixed , MLmed , and SPIRIT . These tools address multilevel mediation analysis, explanatory IRT modeling, and generalized linear mixed models. Key grants include the Federal Graduate Psychology Education Programs (Bureau of Health Professions) and projects on autism spectrum disorder, sleep behaviors, and parenting stress. His work bridges statistical innovation with practical accessibility for researchers. Software contributions include the MLmed SPSS macro for multilevel mediation, SPIRIT for IRT analysis, and PLmixed for R. These tools are widely used in behavioral and health sciences.

• Genetic Testing
• Cancer Risk Management
• Public Health
• +3 more

Dr. Lara Petelin is a Postdoctoral Research Fellow at the Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney. She specializes in genetic testing, cancer risk management, and cost-effectiveness analysis, with a focus on BRCA mutations and Lynch syndrome. Current affiliation: Sydney School of Public Health Academic role: Research Fellow Research Interests: Dr. Petelin's work centers on optimizing genetic counseling protocols, evaluating population genomic screening strategies, and developing models for cancer risk management in hereditary syndromes. Her research integrates public health, clinical genetics, and health economics. Publications Trends: Recent articles emphasize microsimulation modeling (NEEMO, miBRovaCAre), BRCA-related cancer prevention, and implementation of genetic counseling tools like the POETIC trial. Collaborations span institutions in Australia and internationally. Scientific Contributions: Key projects include cost-effectiveness analyses for BRCA mutation carriers, evaluation of telephone genetic counseling accessibility, and development of polygenic risk modification frameworks.

Jonathan D. MosleyView profile

Associate Professor

• Genetics
• Clinical Medicine
• Polygenic Risk Scores
• +7 more

Jonathan D. Mosley, M.D., Ph.D., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center. He is a clinically trained physician scientist with expertise in epidemiology and molecular genetics. His educational background includes: M.D./Ph.D. from Case Western Reserve University Master's in Chronic Disease Epidemiology from Johns Hopkins Bloomberg School of Public Health Residency in Internal Medicine at Vanderbilt University Medical Center Dr. Mosley's research focuses on translating complex genetics to clinical medicine, with particular emphasis on: Developing and implementing polygenic methods for clinical decision-making Identifying biomarkers through multi-omics approaches (metabolomics, proteomics) Studying how benign genetic variations create vulnerable populations Reducing health inequities through genomic research Applications in prostate cancer, cardiac disease, and pharmacogenomics His publications (2016-2025) demonstrate extensive work in genetic risk prediction, particularly using polygenic scores across diverse clinical areas including cardiology, oncology, and hematology. Recent articles show increasing focus on health disparities and clinical implementation of genetic findings. Awards and Recognition: Fellow of the American Heart Association Research Leadership: He directs the Mosley Lab, which specializes in applying genomic and informatics approaches to improve healthcare delivery and reduce inequities through: Integration of electronic health records with biobank data Development of clinical prediction models Identification of genetically vulnerable populations

Kathleen ZhangView profile

Assistant Professor

• Cardio-Oncology
• Cardiac Amyloidosis
• Cardiovascular Disease
• +2 more

Kathleen Zhang, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center, specializing in cardio-oncology and cardiac amyloidosis. She joined the faculty in 2022 after completing her medical degree and internal medicine residency at the University of Pennsylvania, followed by cardiology and cardio-oncology fellowships at Washington University School of Medicine in St. Louis. She holds certifications from the American Board of Internal Medicine (Internal Medicine, Cardiovascular Disease) and the National Board of Echocardiography. Her research focuses on cardiovascular care for cancer patients throughout treatment phases and advancing diagnosis/management of cardiac amyloidosis. She investigates imaging biomarkers, drug cardiotoxicity, and epidemiological patterns in cancer survivors. Dr. Zhang's publications (2020-2021) predominantly explore cardio-oncology interventions, amyloidosis diagnostics, echocardiographic innovations, and cancer therapy cardiovascular outcomes. Her work integrates clinical studies, mechanistic reviews, and practical guidelines. Honors & Awards: Fellow, American College of Cardiology Fellow, International Cardio-Oncology Society She serves as co-editor of the Washington Manual of Cardio-Oncology and associate editor for the International Cardio-Oncology Society Board Review Manual , while reviewing for journals including Heart and JACC: CardioOncology .

• Physical Activity
• Health
• Exercise Physiology
• +2 more

Anouska M Carter is a Researcher at the Academy of Sport and Physical Activity at Sheffield Hallam University . She leads the Physical Activity Wellbeing and Public Health Research Group and has a 15-year track record of grants and contracts from organizations including the MS Society , Innovate UK , and Sport England . PhD in Exercise and Health (Multiple Sclerosis) from Sheffield Hallam University (2008-2016) MSc in Sport and Exercise Physiology from Manchester Metropolitan University BSc (First Class Hons) in Sport and Exercise Science from Manchester Metropolitan University Her research interests focus on Multiple Sclerosis , Workplace Wellbeing , Exercise Physiology , and Health Promotion . She has developed physical activity pathways for MS patients and investigated barriers to workplace health programs, particularly among ethnic minorities. Her article trends emphasize MS rehabilitation , workplace health technology , and behavioral interventions . Recent work includes probiotic trials, exoskeleton training, and seismocardiography device evaluations. Scientific award: Wellbeing Accelerator (2022) She has contributed to 80 publications , including journal articles on cardiometabolic health , prostate cancer , and MS rehabilitation . Her team includes collaborators like Liam Humphreys, Katharine Platts, and Sue Kesterton.

David MathesonView profile

Senior Lecturer

• Prostate Cancer
• Medical Education
• Quality of Life in Healthcare
• +5 more

Dr. David Matheson is a Reader in Education at the University of Wolverhampton's Faculty of Education, Health and Wellbeing. He serves as a Postgraduate Research Tutor, Course Leader for the Professional Doctorate in Health and Wellbeing, and leads research initiatives related to prostate cancer and patient-centered healthcare. His work focuses on clinical trials, patient involvement, and healthcare education reform. PhD, MEd, BSc, and PGCE from the University of Glasgow Senior Fellow of the Higher Education Academy (SFHEA) His research interests span prostate cancer, quality of life in long-term conditions, equality in healthcare, and leadership in education. He collaborates with NHS trusts and leads projects like the Wolverhampton Assessment Tool for advanced prostate cancer patients. His recent publications address oncological treatments, patient experience, and healthcare disparities. As a Senior Lecturer, he supervises 12 doctoral students and contributes to undergraduate, postgraduate, and CPD modules for healthcare professionals. His editorial roles include BMC Medical Education and the Springer Handbook for Promoting Social Justice in Education. He chairs patient panels for Prostate Cancer Research and participates in major trials like STAMPEDE. Scientific Awards Senior Fellow of the Higher Education Academy (SFHEA) Professional Activities Chair of patient panels for Prostate Cancer Research Member of STAMPEDE Trial Management Group Editorial Board Member, BMC Medical Education Advisor on educational programs for NHS West Midlands Researcher in STOPCaP meta-analyses

• Topology
• Soft Set Theory
• Rough Set Theory
• +3 more

Zehra GÜZEL ERGÜL is a Lecturer in the Department of Mathematics at Ahi Evran University of Kirşehir, Turkey. She has served in this role since 2018, previously holding the position of Research Assistant from 2008 to 2018. Her academic leadership includes chairing the Department of Mathematics since 2022. PhD in Mathematics (2015), Selçuk University Master's in Mathematics (2009), Selçuk University Bachelor's in Mathematics (2006), Gazi University Her research focuses on Topology , particularly in Soft Set Theory and its applications to Rough Sets , Multicriteria Decision Making , and Medical Diagnosis . Her work explores decomposition of soft continuity, weak soft structures, and soft covering models. Key publications include studies on prostate cancer diagnosis using soft expert sets (2022), inverse soft covering-based rough sets (2023), and soft continuity decompositions (2023). Collaborations span institutions in Turkey, Ukraine, and Hungary. She supervises graduate theses like: "Esnek Maksimal Kavramı Yardımıyla Yeni Tür Esnek Örtü Tabanlı Kaba Kümeler" (2025) "Bazı Esnek Örtü Tabanlı Kaba Kümelerin Yeni Karakterizasyonları" (2025) Her funded projects include: "Belirsizlik Modellemeye Yeni Bir Bakış Açısı" (2025-2026) "Prostat Kanseri Teşhisi İçin Çok Kriterli Karar Verme" (2023-2024)

• Urology
• Surgical Medicine
• Renal Diseases
• +3 more

Professor İlker Seçkiner is a prominent academic and practicing urologist at Gaziantep University Faculty of Medicine , where he has served as a Professor in the Department of Surgical Medical Sciences since 2013. His career spans multiple institutions, including Bülent Ecevit University and Ankara University, where he previously held academic positions from 1995 to 2000. Specializing in urology , he has published extensively on pediatric urology, renal stone diseases, laparoscopic techniques, and applications of artificial neural networks in clinical decision-making. Current Position: Professor, Gaziantep University Faculty of Medicine Previous Academic Roles: Associate Professor (2008-2013), Assistant Professor (2002-2008) Education: Ankara University Faculty of Medicine (1995-2000) His research focuses on minimally invasive urological procedures , including retrograde intrarenal surgery , percutaneous nephrolithotomy , and laparoscopic applications . He has pioneered the use of machine learning in predicting treatment outcomes for stone diseases. With over 33 book chapters and 104 peer-reviewed articles , his work emphasizes pediatric urology , prostate cancer , and urodynamic studies . His recent articles analyze laser settings in lithotripsy, comparative cost-efficiency of ureteroscopes, and neural network-based predictive models. As a leader in urological surgical education , he has presented at international conferences (International Continence Society, European Congress of Obstetrics) and contributed to national guidelines through Turkish Urology Association publications. His clinical expertise includes complex stone disease management , post-prostatectomy incontinence , and urogenital fistula repairs , often integrating innovative technology into traditional practices.

• Biomedical Robotics
• Microrobotics
• Soft Robotics
• +5 more

Gongxin Li is an Associate Professor at the Institute of Automation, Jiangnan University, affiliated with the Key Laboratory of Advanced Process Control for Light Industry of the Ministry of Education. His research focuses on developing biohybrid robotic systems and microscale technologies for medical diagnostics and interventions. He received his B.Eng. degree from Shantou University in China and his Ph.D. from the Shenyang Institute of Automation, Chinese Academy of Sciences in 2017. Dr. Li's research spans Biomedical Robotics , Microrobotics , and Optogenetics , with emphasis on earthworm-inspired soft robots for gastrointestinal procedures, dielectrophoresis-based cell manipulation, and biohybrid sensors for cancer diagnostics. His work integrates optical/magnetic control systems with microfluidics to address challenges in tumor grading, gut microbiota regulation, and infection detection. Recent publications reveal a consistent focus on minimally invasive medical robotics, showing strong progression from fundamental micromanipulation techniques toward clinically applicable devices like colon-sampling soft robots and gut microbiota regulators. Key trends include biomimetic design, multi-modal control systems, and real-time diagnostic integration. No scientific awards were documented in the source material. Dr. Li serves as Review Editor for Nano- and Microrobotics in Frontiers in Robotics and AI. The source material contained no details regarding student advising or research grants. His laboratory work centers on the Key Laboratory of Advanced Process Control for Light Industry, where he develops automation technologies specifically targeting biomedical applications in gastrointestinal medicine and cancer diagnostics.

David LopezView profile

Assistant Professor

• Epidemiology
• Cancer Epidemiology
• Prostate Cancer
• +4 more

David Lopez is an Assistant Professor in Epidemiology, passionate about teaching and mentoring future epidemiologists. He focuses on cancer epidemiology, particularly prostate cancer and men's health, while emphasizing rigorous epidemiologic methods. Postdoctoral training at Johns Hopkins Bloomberg School of Public Health under Dr. Elizabeth Platz Active member of the SER-Diversity and Inclusion Committee Research interests include cancer health disparities and testosterone studies His dedication to public health education is evident in his teaching philosophy, where he emphasizes identifying a personal 'public health calling' to drive impactful research. Outside academia, he enjoys outdoor activities like barbecuing and spending time with his family.